Drug Giant Eli Lilly Outsources Clinical Data to India - InformationWeek
IoT
IoT
IT Leadership // IT Strategy
News
11/15/2006
12:20 PM
50%
50%
RELATED EVENTS
The Real Impact of a Data Security Breach
Aug 02, 2017
In this webcast, experts discuss the real losses associated with a breach, both in the data center ...Read More>>

Drug Giant Eli Lilly Outsources Clinical Data to India

Tata Consultancy Services will provide Lilly with a range of services, including data management, statistical analysis, and medical writing from a new site near New Delhi dedicated to providing services for Lilly.

U.S. pharmaceutical manufacturing giant Eli Lilly and Co. has agreed to outsource a range of clinical data management services to India's Tata Consultancy Services, TCS said Wednesday.

TCS said the deal is a multiyear engagement of undisclosed value. Indian media reports pegged the deal's worth at about $35 million. A TCS spokesman said he was unable to confirm those reports or provide further details.

TCS will provide Lilly with a range of services, including data management, statistical analysis, and medical writing, TCS said in a statement. The functions will be performed at a new TCS site near New Delhi dedicated to providing services for Lilly. TCS maintains about 2,700 employees in its life sciences practice, which accounts for about 4% of the company's total sales.

Eli Lilly said the decision to outsource goes beyond cost cutting. "The goal of our relationship with TCS has several dimensions beyond reducing cost and risk, including gaining access to a global talent pool, increasing flexibility and scalability of our resources, and maintaining a global workflow that is operational 24 hours a day," said Dr. Steve Ruberg, group director for global medical information sciences at Eli Lilly, in a statement.

TCS's deal with Lilly is the latest indication that India's top outsourcers are poised to move well beyond the basic tech and business services for which they're mostly known. Other countries are also stepping up to attract high-level life sciences work. Last week, drug giant Novartis disclosed plans to build a $100 million research and development facility in China.

Comment  | 
Print  | 
More Insights
Comments
Newest First  |  Oldest First  |  Threaded View
How Enterprises Are Attacking the IT Security Enterprise
How Enterprises Are Attacking the IT Security Enterprise
To learn more about what organizations are doing to tackle attacks and threats we surveyed a group of 300 IT and infosec professionals to find out what their biggest IT security challenges are and what they're doing to defend against today's threats. Download the report to see what they're saying.
Register for InformationWeek Newsletters
White Papers
Current Issue
IT Strategies to Conquer the Cloud
Chances are your organization is adopting cloud computing in one way or another -- or in multiple ways. Understanding the skills you need and how cloud affects IT operations and networking will help you adapt.
Video
Slideshows
Twitter Feed
Sponsored Live Streaming Video
Everything You've Been Told About Mobility Is Wrong
Attend this video symposium with Sean Wisdom, Global Director of Mobility Solutions, and learn about how you can harness powerful new products to mobilize your business potential.
Flash Poll